checkAd

    Erster Thread: BacTech/Mintek Biogold Plant Wins Environmental Award handelbar in Berlin - 500 Beiträge pro Seite

    eröffnet am 21.11.06 18:39:39 von
    neuester Beitrag 09.02.07 17:22:14 von
    Beiträge: 5
    ID: 1.095.829
    Aufrufe heute: 0
    Gesamt: 1.564
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 21.11.06 18:39:39
      Beitrag Nr. 1 ()
      NOVEMBER 21, 2006 - 12:20 ET

      BacTech/Mintek Biogold Plant Wins Environmental Award

      TORONTO, ONTARIO--(CCNMatthews - Nov. 21, 2006) - BacTech Mining Corporation (TSX VENTURE:BM)("BacTech") is pleased to learn that its patented BACOX technology has recently been included in an award given to Michelago Limited ("Michelago") in China. The award, deemed the Mining Environmental Protection Award, was issued at the inaugural China Mining 2006 awards ceremony in Beijing.

      Michelago's Biogold facility in Shandong province has operated a bioleach plant since 2001. The plant, designed by BacTech and Mintek of South Africa, liberates gold from difficult to treat concentrates. BacTech/Mintek issued a license to Michelago on February 20, 2005 (the effective date) for a 5 year period, extendible for an additional 5 years on the same terms and conditions set out in the original license, subject to Michelago not being in default of the license at the time of renewal. In addition, BacTech/Mintek hold an option to purchase up to a 30% equity interest, at a fair market value, in any new projects acquired or developed by Michelago in the agreed to territories which use the BACOX technology.

      The Biogold plant is presently undergoing an expansion, overseen by BacTech's Dr. Paul Miller, that should see a doubling of gold production from the bioleach facility to over 150,000 ounces of gold per annum. A royalty will be paid by Michelago to BacTech/Mintek from this additional production.

      CORPORATE PROFILE

      BacTech has developed and patented bacterial oxidation technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. BacTech has successfully commissioned three bioleach plants for gold and demonstrated its technology in the selective recovery of base metals from complex sulphide concentrates in a joint project with Industrias Penoles de C.V. of Mexico. The Company's focus is the acquisition of equity positions in projects amenable to bioleaching.

      Shares outstanding 52,006,134

      The TSX Venture Exchange has not reviewed and does not accept any responsibility for the adequacy or accuracy of this release.

      CONTACT INFORMATION
      BacTech Mining Corporation
      Ross Orr
      President & CEO
      (416) 813-0303 ext 222
      (416) 595-9840 (FAX)
      Email: info@bactech.com
      Website: www.bactech.com
      Avatar
      schrieb am 26.01.07 16:51:32
      Beitrag Nr. 2 ()
      Und der Bäckermeister empfiehlt BacTech
      Avatar
      schrieb am 26.01.07 16:52:44
      Beitrag Nr. 3 ()
      Antwort auf Beitrag Nr.: 27.202.078 von Hotel-Mama am 26.01.07 16:51:32JANUARY 26, 2007 - 09:14 ET Show Text
      Show Financial Table(s)
      Show All


      BacTech Announces Uranium Joint Venture

      TORONTO, ONTARIO--(CCNMatthews - Jan. 26, 2007) - BacTech Mining Corporation ("BacTech" or the "Company") (TSX VENTURE:BM) today announced the establishment of a uranium Joint Venture with Quinto Mining Corp. ("Quinto")(TSX VENTURE:QU) in Quebec. BacTech will pay Quinto a prospect fee of $25,000 (all figures Canadian) and commit to a $300,000 work program to earn a 50% interest in the property. At the end of the work program, to be completed within one year, BacTech will have an option to earn an additional 25% by spending $1 million in the ensuing 12 months.

      The Quinto property ("Godbout"), located near Baie Comeau, totals 151 claims and consists of three pegmatite dykes over 1.5km. The property has been previously worked. The work includes a grab sample from each dyke, as well as a single exploratory hole that was drilled in 1979 and partially completed. The drill result report was signed and submitted to the Ministere de L'Energie et des Ressources by Mr. Francois Gilbert, ING. The results of the sampling were provided by Mr. Etienne Forbes P.Geo. The following results from both the drill hole and the sampling are not NI 43-101 compliant; they are provided for historical reference and should not be relied upon.



      -----------------------------------------------------------Results of sampling U3O8 THO2-----------------------------------------------------------Discovery hole dyke 2006 ppm 240.5 ppm-----------------------------------------------------------White pegmatite dyke 261 ppm 249 ppm-----------------------------------------------------------Lac des Iles dyke 1323 ppm 561 ppm-----------------------------------------------------------
      -----------------------------------------------------------Results of drilling 45 to 55 feet 45 to 60 feet-----------------------------------------------------------Over 10 feet 1.08 lbs U3O8-----------------------------------------------------------Over 15 feet .89 lbs U3O8-----------------------------------------------------------




      The dynamics of the current uranium market are such that, when presented with this opportunity, the Board of BacTech made the decision to pursue the project. It must be stressed at this time, that BacTech will continue to pursue bioleaching projects for its proprietary technology as its core business. We are currently evaluating a number of bioleach opportunities in several countries, but selecting the right project and completing due diligence is an ongoing process. It has been the strategy of BacTech to move forward in becoming a metals producer in a range of commodities related to its technical expertise. "We see the Quinto project as being an opportunistic acquisition, turning BacTech from a pure technology leveraged mining company, to a mining company with technology leverage," said Ross Orr, BacTech's President and CEO.

      In connection with the transaction, a finder's fee of $31,875 will be paid to Starlight Capital Partners, by way of 303,572 common shares of the Company at an issue price of $0.105, subject to approval by the TSX Venture Exchange. The common shares issued will be subject to a four-month hold period from the date of issuance.

      CORPORATE PROFILE

      BacTech has developed and patented bacterial oxidation technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. BacTech has successfully commissioned three bioleach plants for gold and demonstrated its technology in the selective recovery of base metals from complex sulphide concentrates in a joint project with Industrias Penoles de C.V. of Mexico. The Company's focus is the acquisition of equity positions in projects amenable to bioleaching.

      CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

      Except for statements of historical fact relating to the Corporation, certain information contained herein constitutes "forward-looking statements". Forward-looking statements are frequently characterized by words such as "plan," "expect," "project," "intend," "believe," "anticipate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. These factors include the inherent risks involved in the exploration and development of mineral properties, the uncertainties involved in interpreting drilling results and other ecological data, fluctuating metal prices, the possibility of project cost overruns or unanticipated costs and expenses, uncertainties relating to the availability and costs of financing needed in the future and other factors described in the section entitled "Risks" in the Company's Management Discussion and Analysis for the Year Ended December 31, 2005. Circumstances or management's estimates or opinions could change. The reader is cautioned not to place undue reliance on forward-looking statements.

      Shares outstanding 52,006,134

      The TSX Venture Exchange has not reviewed and does not accept any responsibility for the adequacy or accuracy of this release.

      CONTACT INFORMATION
      BacTech Mining Corporation
      Ross Orr
      President & CEO
      (416) 813-0303 ext 222
      (416) 596-9840 (FAX)
      Email: info@bactech.com
      Website: www.bactech.com
      Avatar
      schrieb am 29.01.07 13:26:38
      Beitrag Nr. 4 ()
      67 % + Was ist da los ?
      Avatar
      schrieb am 09.02.07 17:22:14
      Beitrag Nr. 5 ()
      Der Bäckermeister empfiehlt:

      Bactech

      http://www.canadianminingnews.com/newsstory1s.htm

      News Release - Thursday, February 08, 2007


      Bactech Announces Board Changes

      Toronto, February 8, 2007 - BacTech Mining Corporation ("BacTech" or
      the "Company") is pleased to announce that David Stevens and Peter
      Coleman have joined the Company's Board of Directors. Messrs. Stevens
      and Coleman replace Directors Peter Ironside and Geoffrey Donohue, who
      tendered their resignations after more than eight years of service to
      the Company.

      Mr. Stevens has over 40 years of international and domestic exploration
      experience, having served as a senior corporate exploration executive
      for 22 of those years. He was Vice President of Exploration for
      Noranda and Senior Vice President of Independence Mining Company and
      its predecessor, Freeport-McMoRan Gold Company. Before joining
      Freeport, he spent 10 years in the international minerals exploration
      division of Exxon.

      Peter Coleman is the President and CEO of the National Citizens
      Coalition, a member-driven government watchdog. Mr. Coleman brings
      additional financial experience and expertise to the Board, and will
      play an important role in helping the Company advance its business
      strategy.

      "The new Board members bring considerable depth to the Company," said
      John Gingerich, Chairman of the Board. "Mr. Stevens has an extensive
      industry network and knowledge base to help the Company develop new
      opportunities, while Peter Coleman's expertise will strengthen our
      financial and governance best practices."

      BacTech continues to build its management team with both mining and
      financial experience to augment the Company's strong technical base.
      The Company remains committed to leveraging its technical experience,
      but will also move forward in its assessment of more traditional
      mineral exploration/development opportunities.

      CORPORATE PROFILE

      BacTech has developed and patented bacterial oxidation technology for
      the treatment of refractory ores and concentrates to enhance the
      recovery of gold, silver and base metals. BacTech has successfully
      commissioned three bioleach plants for gold and demonstrated its
      technology in the selective recovery of base metals from complex
      sulphide concentrates in a joint project with Industrias Peñoles de
      C.V. of Mexico that was completed in 2001. The Company's focus is the
      acquisition of equity positions in projects amenable to bioleaching.
      Recently, the Company expanded its focus through the establishment of a
      uranium Joint Venture with Quinto Mining Corp. in Quebec.

      For further information contact:

      Ross Orr, President & CEO 416-813-0303 ext 222

      Shares outstanding 52,006,134

      The TSX Venture Exchange has not reviewed and does not accept any
      responsibility for the adequacy or accuracy of this release

      Copyright (c) 2007 BACTECH MINING CORPORATION (BM) All rights
      reserved. For more information visit our website at
      http://www.bactech.com/ or send mailto:info@bactech.com


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      Erster Thread: BacTech/Mintek Biogold Plant Wins Environmental Award handelbar in Berlin